Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Non-Muscle Invasive Bladder Neoplasms 2Head and Neck Neoplasms 2Voice Disorders 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Pleural Diseases 1Papilloma 1Ototoxicity 1Mesothelioma 1Laryngeal Neoplasms 1Hearing Loss 1Goiter 1Esophageal Neoplasms 1Deglutition Disorders 1Cystitis, Interstitial 1Arthralgia 1

Interventions

Anastrozole 5Letrozole 4Surveys and Questionnaires 3Aromatase Inhibitors 3exemestane 2Testosterone 2Fatty Acids, Omega-3 2Exercise 2Educational Status 2Acupuncture Therapy 2methyl hydroxyethyl cellulose 1guizhi-shaoyao-zhimu decoction 1canakinumab 1Yoga 1Walking 1Vitamin B 12 1Therapeutics 1Tamoxifen 1Occupational Therapy 1Hyaluronic Acid 1Glucosamine 1Glucaric Acid 1Gabapentin 1Fish Oils 1Docosahexaenoic Acids 1Diphosphonates 1Diet Therapy 1Denosumab 1Curcumin 1Chondroitin Sulfates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthralgia × Hyaluronic Acid × Clear all
NCT03384095 2019-01-02

Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

Indiana University

Phase 2 Withdrawn

Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡